Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Masson

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Acta Gastroenterologica Latinoamericana|December 4, 2025
[[The Future of Clinical Trials]]Walter Masson
Acta Gastroenterologica Latinoamericana|December 4, 2025
[[Key Concepts in Pretest Probability Estimation]]Walter Masson
Acta Gastroenterologica Latinoamericana|December 4, 2025
[[Win Ratio: A Different Way to Analyze Clinical Trials. Its Strengths and Weaknesses]]Walter Masson
Acta Gastroenterologica Latinoamericana|December 4, 2025
Walter Masson
Archivos De Cardiologia De Mexico|September 30, 2025
[GLP-1 receptor agonists: it is time to assess major adverse limb events in clinical trials]Fernando Garagoli, Walter Masson
Current Problems in Cardiology|June 4, 2026
Lipid-lowering therapy in acute coronary syndrome: Limitations of the stepwise approach and rationale for a 'strike early, strike strong' strategyBenjamin Rossi, Walter Masson
Advances in Therapy|April 22, 2020
Psoriasis and Cardiovascular Risk: A Comprehensive ReviewWalter Masson, Martín Lobo, Graciela Molinero
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 21, 2024
Association between elevated lipoprotein(a) levels and vulnerability of carotid atherosclerotic plaque: A systematic reviewFernando Garagoli, Walter Masson, Leandro Barbagelata
Current Neurology and Neuroscience Reports|January 31, 2026
Effect of non-statin Therapy on the Composition and Characteristics of Carotid Atherosclerotic Plaques: A Systematic ReviewFernando Garagoli, Walter Masson, Leandro Barbagelata
Journal of Lipid and Atherosclerosis|October 6, 2025
Effect of Non-Statin Lipid-Lowering Therapy on Hepatic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic ReviewWalter Masson, Leandro Barbagelata, Juan Patricio Nogueira
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Acta Gastroenterologica Latinoamericana|December 4, 2025
[[The Future of Clinical Trials]]Walter Masson
Acta Gastroenterologica Latinoamericana|December 4, 2025
[[Key Concepts in Pretest Probability Estimation]]Walter Masson
Acta Gastroenterologica Latinoamericana|December 4, 2025
[[Win Ratio: A Different Way to Analyze Clinical Trials. Its Strengths and Weaknesses]]Walter Masson
Acta Gastroenterologica Latinoamericana|December 4, 2025
Walter Masson
Archivos De Cardiologia De Mexico|September 30, 2025
[GLP-1 receptor agonists: it is time to assess major adverse limb events in clinical trials]Fernando Garagoli, Walter Masson
Current Problems in Cardiology|June 4, 2026
Lipid-lowering therapy in acute coronary syndrome: Limitations of the stepwise approach and rationale for a 'strike early, strike strong' strategyBenjamin Rossi, Walter Masson
Advances in Therapy|April 22, 2020
Psoriasis and Cardiovascular Risk: A Comprehensive ReviewWalter Masson, Martín Lobo, Graciela Molinero
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 21, 2024
Association between elevated lipoprotein(a) levels and vulnerability of carotid atherosclerotic plaque: A systematic reviewFernando Garagoli, Walter Masson, Leandro Barbagelata
Current Neurology and Neuroscience Reports|January 31, 2026
Effect of non-statin Therapy on the Composition and Characteristics of Carotid Atherosclerotic Plaques: A Systematic ReviewFernando Garagoli, Walter Masson, Leandro Barbagelata
Journal of Lipid and Atherosclerosis|October 6, 2025
Effect of Non-Statin Lipid-Lowering Therapy on Hepatic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic ReviewWalter Masson, Leandro Barbagelata, Juan Patricio Nogueira
Pageof 11